TY  - GEN
AU  - Huet,Sarah
AU  - Cony-Makhoul,Pascale
AU  - Heiblig,Maël
AU  - Tigaud,Isabelle
AU  - Gazzo,Sophie
AU  - Belhabri,Amine
AU  - Souche,Denis
AU  - Michallet,Mauricette
AU  - Magaud,Jean-Pierre
AU  - Hayette,Sandrine
AU  - Nicolini,Franck
TI  - Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended
SN  - 1932-6203
PY  - 2015///0518
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Female
KW  - Follow-Up Studies
KW  - Fusion Proteins, bcr-abl
KW  - genetics
KW  - Gene Expression Regulation, Neoplastic
KW  - drug effects
KW  - Glucuronidase
KW  - Humans
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - diagnosis
KW  - Male
KW  - Middle Aged
KW  - Protein Kinase Inhibitors
KW  - pharmacology
KW  - RNA, Messenger
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1371/journal.pone.0106250
ER  -